{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:30:52Z","timestamp":1784694652471,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.cardfail.2014.05.010","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T16:45:50Z","timestamp":1401900350000},"page":"560-568","source":"Crossref","is-referenced-by-count":50,"title":["Effects of Spironolactone Treatment in Elderly Women With Heart Failure and Preserved Left Ventricular Ejection Fraction"],"prefix":"10.1016","volume":"20","author":[{"given":"Karla M.","family":"Kurrelmeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif F.","family":"Nagueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Torre-Amione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Deswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2014.05.010_bib1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2014.05.010_bib3","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.010_bib4","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2014.05.010_bib5","first-page":"155","article-title":"Factors influencing diastolic function\u2013possible role of the extracellular-matrix","volume":"81","author":"Covell","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.010_bib6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/0735-1097(93)90560-N","article-title":"Influence of collagen network on left-ventricular systolic and diastolic function in aortic-valve disease","volume":"22","author":"Villari","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","article-title":"Escape of aldosterone production in patients with left-ventricular dysfunction treated with an angiotensin-converting enzyme-inhibitor\u2013implications for therapy","volume":"9","author":"Pitt","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cardfail.2014.05.010_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","article-title":"Rise in plasma-concentration of aldosterone during long-term angiotensin (II) suppression","volume":"91","author":"Staessen","year":"1981","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.010_bib10","doi-asserted-by":"crossref","first-page":"165A","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib11","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure\u2014insights from the Randomized Aldactone Evaluation Study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.010_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2014.05.010_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/hc0502.103010","article-title":"Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings","volume":"105","author":"Lubien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.010_bib14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1054\/jcaf.2001.25652","article-title":"Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure","volume":"7","author":"Packer","year":"2001","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.010_bib16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2014.05.010_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.echo.2011.12.019","article-title":"Prognostic value of tricuspid annular tissue Doppler velocity in heart failure with atrial fibrillation","volume":"25","author":"Kim","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2014.05.010_bib18","series-title":"Applied longitudinal analysis","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.cardfail.2014.05.010_bib19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCULATIONAHA.106.661983","article-title":"Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction\u2014a comparative Doppler-conductance catheterization study","volume":"116","author":"Kasner","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.010_bib21","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","article-title":"Results of the Predictors of Response to CRT (PROSPECT) trial","volume":"117","author":"Chung","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.010_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Monitoring clinical changes in patients with heart failure: a comparison of methods","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2014.05.010_bib23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2005.11.021","article-title":"Health status identifies heart failure outpatients at risk for hospitalization or death","volume":"47","author":"Heidenreich","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0002-9149(02)03433-1","article-title":"Impact of left ventricular election fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity","volume":"91","author":"Rivas-Gotz","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib25","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2009.08.021","article-title":"Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone","volume":"54","author":"Mak","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","article-title":"Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF)","volume":"17","author":"Deswal","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.010_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2014.05.010_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spironolactone to an angiotensin-converting enzyme-inhibitor in chronic congestive-heart-failure secondary to coronary-artery disease","volume":"76","author":"Barr","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1291\/hypres.24.99","article-title":"High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients","volume":"24","author":"Sato","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cardfail.2014.05.010_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejheart.2005.06.008","article-title":"Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes","volume":"8","author":"Alla","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.010_bib31","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.106.638569","article-title":"Diastolic Heart Failure: Evidence of increased myocardial collagen turnover linked to diastolic dysfunction","volume":"115","author":"Martos","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.010_bib32","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure\u2013Insights from the randomized aldactone evaluation study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.05.010_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/CIRCHEARTFAILURE.110.960716","article-title":"Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction results of the I-PRESERVE collagen substudy","volume":"4","author":"Krum","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.010_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2009.10.022","article-title":"Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure","volume":"159","author":"Tsutamoto","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2014.05.010_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2014.05.010_bib36","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])","volume":"78","author":"Pitt","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2014.05.010_bib37","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T07:55:10Z","timestamp":1565510110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916414002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1071916414002152"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.05.010","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}